newsfilter
← Latest News
GlobeNewswire·

BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update

Two SITC 2025 presentations: First-in-class dendritic cell (DC) maturation agent Plinabulin drives immune re-sensitization in metastatic NSCLC patients who had progressed after PD-1/L1 inhibitors with disease control